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Abstract
Purpose—Self-reported weight, height and body mass index (BMI) are commonly used in 
cancer epidemiology studies, but information on the validity of self-reports among cancer 
survivors is lacking. This study aimed to evaluate the validity of these self-reported measures 
among African American (AA) breast cancer survivors, known to have a high obesity prevalence.
Methods—We compared the self-reported and measured values among 243 participants from the 
Women’s Circle of Health Follow-Up Study (WCHFS), a population-based longitudinal study of 
AA breast cancer survivors. Multivariable-adjusted linear regressions were used to identify factors 
associated with reporting errors. We also examined the associations of self-reported and measured 
BMI with obesity-related health outcomes using multivariable logistic regressions, with 
hypertension as an example, to evaluate the impact of misreporting.
Results—We found that self-reported and measured values were highly correlated among all and 
when stratified by participants’ characteristics (intraclass correlation coefficients ≥0.99, 0.84 and 
0.96 for weight, height and BMI, respectively). The agreement between BMI categories (normal, 
overweight and obese) based on self-reported and measured data was excellent (kappa=0.81). 
Women who were older, never smoked, had higher grade tumors or greater BMI tended to have 
over-estimated BMI calculated from self-reported weight and height. The BMI-hypertension 
association was similar using self-reported (OR per 5 kg/m2 increase: 1.63; 95% CI: 1.27–2.10) 
and measured BMI (1.58; 95% CI: 1.23–2.03).
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Conclusions—Self-reported weight, height and BMI were reasonably accurate in the WCHFS.
Implications—Our study supports the use of these self-reported values among cancer survivors 
when direct measurements are not possible.
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INTRODUCTION
Body mass index (BMI), an index of weight adjusted for height, is used in clinical settings 
and epidemiological studies to indicate body fatness and obesity. Higher BMI and obesity 
are associated with multiple health problems in the general population. They are also risk 
factors for adverse cancer outcomes, such as a higher risk of all-cause and breast cancer-
specific mortality among breast cancer patients [1].
Self-reports, rather than measured values, are often used to collect data on height and weight 
and to calculate BMI, because self-reports are easy to acquire and time- and cost-efficient, 
especially in large population-based studies. In addition, there are situations when collecting 
self-reports are more feasible; for example, cancer patients may sometimes be unwilling 
and/or unable to participate in in-person interviews (i.e., face-to-face). Therefore, many 
cancer epidemiology studies have relied on self-reports to evaluate the role of obesity in 
cancer outcomes [2–7].
Previous studies, mostly based on general adult populations, suggest trends of under-
reporting for weight, particularly in women, and over-reporting for height, particularly 
among older adults [8, 9]. Therefore, BMI calculated based on self-reported weight and 
height (referred to as “self-reported BMI”) tends to be systematically underestimated, and 
the inaccurate BMI categorization may result in substantial errors in estimating mortality 
hazard associated with obesity [10–12]. However, it remains unknown if cancer survivors 
report their anthropometric values accurately. Breast cancer survivors, for example, may 
experience treatment-induced weight gain or weight loss [13, 14], but they may watch their 
weight status more closely than the general population. Furthermore, limited and 
inconsistent evidence has been available with respect to whether African Americans, who, 
on average, have higher BMI than their white counterparts [15], are more prone to 
underestimate their BMI [16–19].
The Women’s Circle of Health Follow-Up Study (WCHFS) has both self-reported and 
measured weight and height among African American breast cancer survivors, thus offering 
us a unique opportunity to compare the two different methods of obtaining anthropometric 
measurements. The primary objective of this study was to evaluate the accuracy of self-
reported weight, height and BMI among African American breast cancer survivors. The 
secondary aim was to identify factors associated with reporting errors.
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METHODS
Study Population
The WCHFS is an ongoing longitudinal study of lifestyle, obesity, obesity-related 
comorbidities, and breast cancer outcomes among African American breast cancer survivors. 
Participants were identified by rapid case ascertainment in 10 counties in New Jersey 
through the New Jersey State Cancer Registry. The study sample for this analysis included 
women who were enrolled in the WCHFS from July 2012 to June 2015. Eligible participants 
included English-speaking women of self-identified Black/African American aged 20–75 
years, who had recently been diagnosed with histologically confirmed ductal carcinoma in 
situ (DCIS) or invasive breast cancer, and who had no history of cancer except non-
melanoma skin cancer.
Data were collected during an in-person home visit occurring approximately 9–12 months 
after diagnosis of breast cancer, and during a follow-up home visit approximately 2 years 
after diagnosis. Both visits included structured questions on socio-demographic, lifestyle, 
and reproductive factors, current comorbidities and medications, family history of cancer, 
and quality of life. Anthropometric measures and blood pressure were also taken, as 
described below. The present analyses were limited to the African American breast cancer 
survivors who completed a follow-up visit. The study was approved by the institutional 
review boards at the Rutgers Cancer Institute of New Jersey and Roswell Park Cancer 
Institute. Informed consent was obtained from all individual participants included in the 
study.
Starting in January 2015, WCHFS began to include self-reported weight during the follow-
up visit, resulting in a sample of 294 women with this information by March 2017. We 
excluded 38 women who did not respond to the self-reported questions for weight or height, 
and an additional 13 participants who did not complete interviewer-administered 
anthropometric assessments, leaving 243 women in this study. None of them were pregnant. 
Women excluded for not having anthropometric data were similar to those included except 
for marital status; excluded women were more likely to be single (data not shown).
Assessment of Anthropometric Data
Participants were asked to report their current weight (in pounds) in the follow-up interview 
and were asked to report their height (in feet and inches) during the baseline interview. 
Current height was not ascertained in the follow-up visit, which was an average of 1.8 years 
after the baseline visit. The self-reported values were converted to metric units for analyses. 
Self-reported BMI was calculated as weight (kg) divided by squared height (m2).
Anthropometric measurements were conducted shortly after the collection of self-reported 
weight during the follow-up visit. Trained interviewers measured weight and height on 
participants in light clothing, and without shoes or any heavy jewelry, following a 
standardized protocol [20]. Weight was measured to the nearest 0.1 kg using digital scales 
(TBF-300A; TANITA Corp.). Height was measured with a vertical ruler to the nearest 0.1 
cm. BMI based on interviewer-measured weight and height was also calculated, and is 
referred to as measured BMI in this paper.
Qin et al. Page 3
J Cancer Surviv. Author manuscript; available in PMC 2019 August 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Assessment of Other Variables
We selected and evaluated factors potentially associated with BMI misreporting based on a 
priori hypotheses. Age, smoking (current, former, never), time since diagnosis (<20 months, 
≥20 months), diabetes (self-report) and hypertension (measured mean SBP/DBP ≥140/90 
mmHg or self-report of antihypertension medications [21]) were collected at the follow-up 
interview. Education (≤high school graduate, ≥some college), marital status (married/living 
as married, single/other), and breast cancer treatments including mastectomy, chemotherapy 
and hormonal therapy (yes, no, unknown) were ascertained at baseline interview. Post-
diagnosis weight change was calculated as measured weight at follow-up minus measured 
weight at baseline. Tumor clinicopathologic data including histologic type (DCIS, invasive, 
unknown), stage (in situ/localized, regional/distant), grade (I, II, III, unknown) and estrogen 
receptor (ER) status (ER+, ER−, unknown) were obtained from the New Jersey State Cancer 
Registry files and patients’ medical and pathology records.
Hypertension, as defined above, was selected as an example of an obesity-related health 
outcome to evaluate the potential impact of BMI misreporting. During the follow-up 
interview, blood pressure was measured using a standard automated blood pressure monitor 
(Omron HEM-907XL; Omron Healthcare) after a 5-minute seated rest at three 1-minute 
intervals and was repeated after half of the interview. A total of six readings were averaged 
to derive the mean blood pressure.
Statistical Analysis
The validity of self-reported weight, height and BMI was assessed in five ways. First, we 
calculated the mean differences between self-reported and measured values (self-report 
minus measured values) and the standard deviation (SD) to understand the direction and 
degree of systematic bias. Second, we calculated Pearson’s correlation coefficients and 
intraclass correlation coefficients (ICCs) using a two-way random-effects model. The former 
does not take into account all the systematic errors but was provided to compare with 
previous studies. The latter was provided as a summary measure of the validity of self-
reports. Third, to visualize and evaluate whether the difference between self-reported and 
measured BMI was related to the magnitude of measurements, we plotted the difference 
against the measured BMI. Finally, since BMI is often categorized when studied as a risk 
factor, we classified it according to World Health Organization definitions (<25, 25–29.9, 
30–34.9, 35–39.9 and ≥40 kg/m2) [22]. The first two BMI categories were combined 
because only one participant was underweight. We assessed the agreement between self-
reported and measured BMI categories using cross-tabulation and Cohen’s kappa [23]. To 
allow a direct comparison with prior studies, we also calculated Cohen’s kappa based on 
three BMI categories (<25, 25–29.9, ≥30 kg/m2).
We used multivariable-adjusted linear regression models to identify factors associated with 
reporting errors. The differences between self-reported and measured weight, height and 
BMI, were used as the outcomes. All factors as listed in Table 1 were considered using 
backward elimination, but only variables with P < 0.10 were retained in the final models.
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We also examined the associations of self-reported and measured BMI with hypertension as 
an example of an obesity-related outcome, to evaluate the impact of potential misreporting. 
The first logistic regression model adjusted for age, and the second model further adjusted 
for education, smoking status, and recreational physical activity levels [24]. All statistical 
analyses were performed using Stata (version 14.2; StataCorp).
RESULTS
Concordance Between Self-Reported and Measured Weight, Height and BMI
Table 1 shows the selected characteristics of African American breast cancer survivors in the 
WCHFS, including the mean differences between self-reported and measured 
anthropometric values. Participants accurately reported their weight but tended to over-
report their height, leading to a lower self-reported BMI by a mean (SD) of 0.41 (1.49) 
kg/m2.
Table 2 shows Pearson’s correlation coefficients and ICCs comparing self-reported and 
measured weight, height and BMI overall and by participants’ characteristics. Self-reported 
and measured anthropometric values were approximately normally distributed in each 
subgroup of selected characteristics. Pearson’s correlations and ICCs for weight among all 
participants and in each subgroup were 0.99 or 1.00. There were greater variations in the 
correlations between self-reported and measured height, with ICC of 0.90 among all and 
with the lowest ICC of 0.84 among participants who were diagnosed at regional/distant 
stages. As expected, the Pearson’s correlation coefficient for height was slightly higher than 
the ICC, suggesting there were some systematic errors associated with self-reported height. 
Self-reported and measured BMI were highly correlated among all participants and across 
subgroups, with both Pearson’s correlation coefficients and ICCs ranging narrowly from 
0.96 to 0.98.
The figure presented in Online Resource 1 supports that the difference between self-reported 
and measured BMI was small. It additionally shows that the negative difference became 
stronger with increased BMI, suggesting that BMI based on self-reported height and weight 
was more likely to be underestimated with increased adiposity.
Cross-tabulation and Cohen’s kappa were used to evaluate the impact of misreporting on 
BMI categories. Because of the high prevalence of severe obesity in our study sample, we 
were able to examine 5 categories of BMI, i.e., normal weight, overweight, and obesity I, II 
and III. Online Resource 2 shows that, overall, 80.7% of self-reported BMI were allocated to 
the correct BMI categories. Except for two participants, the rest were allocated to adjacent 
BMI categories. The agreement between self-reported and measured BMI categories was 
good (kappa = 0.75). The kappa coefficient based on three categories, i.e., normal weight, 
overweight and obesity, suggests excellent agreement (kappa = 0.81).
Predictors of Self-Reported Errors
Table 3 shows factors that, after backward elimination, were associated with differences 
between self-reported and measured BMI, weight, and height respectively. Women who 
were 65 years or older or had grade II tumors were borderline significantly associated with 
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underestimation of BMI compared with women who were less than 55 years or had grade I 
tumors, respectively (P = 0.08 or 0.07). Women who had greater BMI were more likely to 
underestimate their BMI (e.g., P = 0.001 comparing ≥ 40 vs. < 25 kg/m2). Current smokers 
were less likely to underestimate their BMI than never smokers (P = 0.03). Women with 
BMI < 25 kg/m2 and women who had lost more than 2% of body weight since baseline 
tended to under-report their weight. Over-reporting of height significantly increased among 
women after age 65 (P = 0.005 vs. < 55 years), who were former smokers (P = 0.03 vs. 
never smoked), or who were diagnosed with grade II tumors (P = 0.04 vs. grade I), and 
borderline significantly increased with BMI of 35–39.9 kg/m2 and ≥ 40 kg/m2 (P = 0.07 and 
0.09, respectively vs. < 25 kg/m2). Other factors (i.e., education, marital status, having 
diabetes or hypertension, time since diagnosis, histologic type, tumor stage, ER status and 
breast cancer treatments including hormonal therapy) were not associated with the self-
reported errors of weight, height or calculated BMI.
Associations of Self-Reported and Measured BMI with Hypertension
As shown in Table 4, we observed positive associations of higher BMI and obesity with 
hypertension, as expected. In the multivariable-adjusted model, the associations between 
higher BMI categories and hypertension tended to be slightly attenuated when using self-
reported values, while the association using continuous self-reported BMI (OR per 5 kg/m2 
increase: 1.63; 95% CI: 1.27–2.10) was similar to that using measured values (OR per 5 
kg/m2 increase: 1.58; 95% CI: 1.23–2.03).
DISCUSSION
In this study of African American breast cancer survivors, we found a low level of mean 
difference and a high degree of correlation between self-reported and measured weight, 
height and BMI. Several factors including older age, never smoking, higher tumor grade and 
greater BMI were associated with BMI misreporting, but they did not substantially influence 
the accuracy of self-reported BMI and the classification of weight status. To our knowledge, 
this is the first study to evaluate the validity of self-reported anthropometric data among 
African American cancer survivors, despite that many studies relied on self-reports in 
assessing the current weight status of participants who had cancer [25–27].
The size of the mean errors in height (1.2 cm or 0.5 in) in our study is in broad agreement 
with previous studies [8]. Among adult women in the EPIC-Norfolk study (Norfolk arm of 
the European Investigation into Cancer and Nutrition study), self-reported height was on 
average 1.4 cm taller than the measured value [28]. In the National Health and Nutrition 
Examination Survey (NHANES) III, the mean height of African American women was 163 
cm (5 ft 4 in), and the mean difference between self-reported and measured height was 0 cm 
among adult women below 60 years of age, and 2.5 cm among women aged 60 years and 
over [9]. To allow a direct comparison, in our study, women’s mean height was 162 cm and 
the mean differences among these two age groups were 0.80 cm and 1.7 cm, respectively. 
Consistent with findings in the general population [9, 28], we found that women with older 
age and higher BMI were more likely to over-report their height, which may be caused by 
height loss in the elderly and cultural pressure. We also found that former or current smokers 
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and women who had grade II or grade III tumors overestimated their height by more than 1 
cm, which may reflect the relation between poorer health status and greater reporting errors.
Self-reported weight was sufficiently accurate in our study. This finding may seem 
surprising as greater BMI is generally associated with more errors in self-reported weight 
[8], and 60% of African American breast cancer survivors in our study had obesity (BMI ≥ 
30 kg/m2) and 14% had severely obesity (BMI ≥ 40 kg/m2). Calculated from interviewer-
measured weight at baseline and follow-up visits, 31% of women had more than 2% weight 
gain and 22% experienced more than 2% weight loss. However, only the weight loss group 
slightly overestimated their weight by 0.6 kg (1.4 lb), and both those with stable weight 
(within 2% of weight fluctuations) and the weight gain groups were able to accurately report 
their current weight. Our finding in self-reported weight differed from the results based on 
general populations [8], such as NHANES, where self-reported weight was on average 1.9 
kg below the measured value among African American women [9]. In the Sister Study, a 
cohort of US women with a sister with breast cancer, their self-reported weight was 
underestimated by a mean of 0.7 kg [29], which was more accurate than that from the 
general population. It is possible that breast cancer survivors are more aware of their weight 
through their more frequent contact with medical professionals than women in the general 
population. Therefore, they are able to report their weight to a greater level of accuracy.
Compared with a mean difference of −0.8 kg/m2 between self-reported and measured BMI 
among African American women in NHANES [9], we found an improved accuracy of self-
reported BMI in our study with a mean difference of −0.4 kg/m2. This small underestimation 
was mainly caused by the overestimated denominator, i.e., self-reported height, for BMI 
calculation. Our observation that the effect of underestimation was more marked with 
increased adiposity is consistent with the previous literature [8]. The same set of factors 
associated with the inaccuracy of self-reported height, i.e., age, smoking status, tumor grade, 
and BMI, also predicted errors in self-reported BMI.
Previous studies recommended using self-reported BMI as a continuous independent 
variable to avoid the potentially more biased risk estimates when using categorical self-
reported BMI [10, 12, 11]. Our findings generally support this recommendation. Although 
we observed good to excellent agreement between self-reported and measured BMI 
categories, we found the multivariable-adjusted odds ratios of having hypertension were 
attenuated with categorical self-reported BMI, meanwhile the estimates were very similar 
when we used continuous BMI. We used hypertension as one example to evaluate the impact 
of potential misreporting, but the findings may be relevant to the study of BMI and other 
comorbidities of breast cancer survivors.
We recognize the limitation that self-reported height was collected at baseline while 
measured height and other anthropometric values used in the current study were collected at 
a subsequent follow-up visit. The rate of stature decline, which is 1 to 2 cm per decade [30], 
may have contributed to the underreported height and the slightly overestimated BMI. We 
might have observed even more accurate self-reports if we had asked participants to report 
their height at the follow-up visit. However, an average 1.8-year lapse between baseline and 
follow-up visits is unlikely to have substantially changed the results. Second, the level of 
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inaccuracy of self-reports could have been underestimated if participants with undesirable 
weight tended to decline the requests for reporting or measuring their weight. This is 
unlikely to have affected our results, given that, except for marital status, we found no 
difference in baseline measured BMI and other participants’ characteristics between women 
with complete self-reported and measured values versus those without. In addition, like 
NHANES [31], the self-reported data in our study were collected through in-person 
interviews, where participants may be less likely to intentionally misreport their weight and 
height compared to the telephone interviews or mail surveys.
A major strength of this study is that there was a greater prevalence of obesity and severe 
obesity than any of the previous studies on this topic, so that we were able to compare the 
accuracy of self-reported BMI among participants with extreme obesity. Although objective 
measures offer the most accurate anthropometric values, the time and efforts associated with 
the in-person interviews and the intrusive nature of such measures may potentially decrease 
response rates and contribute to attribution bias in follow-up studies of cancer survivors. Our 
study supports the use of self-reported BMI among cancer survivors when direct 
measurements are not possible.
CONCLUSIONS
Our findings suggest that self-reported weight, height and BMI were reasonably accurate 
among African American breast cancer survivors, but may lead to some degree of systematic 
misreporting in certain subgroups, such as women with older age, higher grade tumors, or 
higher BMI. When evaluating associations with BMI, self-reported BMI as a continuous 
variable may provide more accurate risk estimates and may be preferable to categorical self-
reported BMI.
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Table 1
Selected characteristics and differences between self-reported and measured anthropometric values among 
African American breast cancer survivors in the WCHFS (n = 243)
n (%)a
Age
 <55 94 (38.7)
 55–<66 89 (36.6)
 ≥65 60 (25.7)
Education
 ≤High school graduate 112 (46.1)
 ≥Some college 131 (53.9)
Smoking status
 Never 129 (53.1)
 Former 75 (30.9)
 Current 39 (16.0)
Marital status
 Married/living as married 86 (35.4)
 Single/other 157 (64.6)
Time since diagnosis
 <20 month 114 (46.9)
 ≥20 month 129 (53.1)
Histologic type
 Ductal Carcinoma In Situ 45 (18.5)
 Invasive Ductal Carcinoma 175 (72.0)
 Unknown 23 (9.5)
Stage
 In situ/Localized 141 (58.0)
 Regional/Distant 75 (30.9)
 Unknown 27 (11.1)
Grade
 I 26 (10.7)
 II 73 (30.0)
 III 97 (39.9)
 Unknown 47 (19.3)
ER status
 ER+ 178 (73.3)
 ER− 51 (21.0)
 Unknown 14 (5.8)
Mastectomy
 No 161 (66.3)
 Yes 81 (33.3)
 Unknown 1 (0.4)
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n (%)a
Chemotherapy
 No 112 (46.1)
 Yes 130 (53.5)
 Unknown 1 (0.4)
Hormonal therapy
 No 122 (50.2)
 Yes 120 (49.4)
 Unknown 1 (0.4)
Diabetes
 No 176 (72.4)
 Yes 67 (27.6)
Hypertension
 No 92 (37.9)
 Yes 151 (62.1)
Post-diagnosis weight change
 >2% loss 54 (22.2)
 ±2% maintain 114 (46.9)
 >2% gain 75 (30.9)
Measured BMI categories
 Normal (<25 kg/m2)b 24 (9.9)
 Overweight (25–29.9 kg/m2) 73 (30.0)
 Obese I (30–34.9 kg/m2) 63 (25.9)
 Obese II (35–39.9 kg/m2) 49 (20.2)
 Obese III (≥40 kg/m2) 34 (14.0)
Self-reported anthropometry
 Weight (kg, mean±SD) 86.1 ±18.5
 Height (cm, mean±SD) 163.1 ±7.2
 BMI (kg/m2, mean±SD) 32.4 ±6.7
Measured anthropometry
 Weight (kg, mean±SD) 85.9 ±18.6
 Height (cm, mean±SD) 161.9 ±6.6
 BMI (kg/m2, mean±SD) 32.8 ±6.9
Difference between self-reported and measured valuesc
 Weight (kg, mean±SD) 0.16 ±2.35
 Height (cm, mean±SD) 1.16 ±2.88
 BMI (kg/m2, mean±SD) −0.41 ±1.49
aValues are n (%) unless otherwise noted.
bOne women was underweight (measured BMI = 17.1 kg/m2) and was included.
c
Difference was calculated as self-reported minus measured value.
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